ChinaBio® Partnering Forum is part of the Informa Connect Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.
Dr. Jenny Liu is the Chief Investment Officer at Livzon Pharmaceutical Group, focusing on outbound investment, collaboration and business development. Previously, Dr. Liu has served extensively in the PE fund and Investment Banking space, with years of experience in overseas capital market for healthcare projects, and has successfully completed multiple biotech and pharmaceutical IPOs and transactions in the HK capital market. Dr. Liu has also worked in the research space at the National Institute of Biological Sciences, and earned her Ph.D. from the Biological and Biomedical Sciences program of Harvard Graduate School of Arts and Sciences and Harvard Medical School.